Wenhua Liang

5PUBLICATIONS
26CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Chemical engineering designInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Oct 16, 2025
TCR signal-enhancing mutation alters lipid metabolism of thymocytes and impairs antitumor immunity of mature T cells.

Wenhua Liang, Yuge Liang, Mingzhu Yu

|Apr 09, 2025
MYO1F in neutrophils is required for the response to immune checkpoint blockade therapy.

Yingying Qu, Wenhua Liang, Mingzhu Yu

|Oct 20, 2022
Enhancing the Antitumor Immunity of T Cells by Engineering the Lipid-Regulatory Site of the TCR/CD3 Complex.

Wenhua Liang, Ruirong Yi, Weifang Wang

|Oct 20, 2020
<i>Bifidobacterium</i> alters the gut microbiota and modulates the functional metabolism of T regulatory cells in the context of immune checkpoint blockade.

Shan Sun, Lingjie Luo, Wenhua Liang

Pageof 1